Announcements Trials

Browse Landscape

Phase

Status

Completed 19 Terminated 6 Recruiting 3 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 117 Recurrence 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Neoplasms, Plasma Cell 13 Neoplasms 8 Burkitt Lymphoma 8 Immunoglobulin Light-chain Amyloidosis 7 Lymphoma, B-Cell 4 Lymphoma 4 Smoldering Multiple Myeloma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Paraproteinemias 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Fatigue 2 Wrist Fractures 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Plasmacytoma 1 Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1 Pancreatic Neoplasms 1

Interventions

enzalutamide 33 Abiraterone Acetate 29 apalutamide 26 Prednisone 26 Radiotherapy 25 Magnetic Resonance Spectroscopy 25 Androgen Antagonists 24 Leuprolide 22 Radiosurgery 19 darolutamide 18 Docetaxel 17 Gonadotropin-Releasing Hormone 16 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15 Goserelin 13 gallium 68 PSMA-11 12 bicalutamide 12 Specimen Handling 12 Radiotherapy, Intensity-Modulated 12 abiraterone 11 Radiation 11 pembrolizumab 10 Pluvicto 10 Carboplatin 9 Brachytherapy 9 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 9 relugolix 8 luprolide acetate gel depot 8 Triptorelin Pamoate 8 Standard of Care 8 Nivolumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Prostatic Neoplasms × Dexamethasone × Clear all

NCT04147806 2026-04-03

PROSINT

Albert Einstein College of Medicine

Phase 1 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡